Article

What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?

Conference|Gastrointestinal Cancers Symposium

Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Lenacapavir | Image Credit: luchschenF | stock.adobe.com
Related Content
Atopic dermatitis. Red, itchy hands with blisters seen by a dermatologist
September 13th 2025

Amlitelimab Meaningfully Clears Skin in Moderate-to-Severe Atopic Dermatitis

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
September 13th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Chronic kidney disease (CKD) -- Image credit: Yurii Kibalnik | stock.adobe.com
September 13th 2025

Baxdrostat Manages High Blood Pressure, Delays Kidney Disease Progression in Patients With CKD

Gillian McGovern, Associate Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
September 13th 2025

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
Illustration from research for genomic medicine or gene therapy.
September 13th 2025

Navigating the Complex Landscape of Sickle Cell Gene Therapy: Operational Challenges and Collaborative Solutions

Luke Halpern, Assistant Editor
Woman with PCOS -- Image credit: SewcreamStudio | stock.adobe.com
September 13th 2025

Study: Women With PCOS at Increased Risk of Acute Myocardial Infarction and Ischemic Stroke

Gillian McGovern, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.